# Medical Referral and Specialist Consultation Scenarios

## Scenario 1: Cardiology Referral - Chest Pain Evaluation

### Patient Profile
- **Name:** David Rodriguez
- **Age:** 45 years
- **Gender:** Male
- **Weight:** 185 lbs (84 kg)
- **Height:** 5'10" (178 cm)
- **BMI:** 26.5
- **Occupation:** Construction manager

### Medical History
- **Primary Reason:** Chest pain evaluation
- **Medical History:**
  - Hypertension (5 years)
  - Dyslipidemia (3 years)
  - Type 2 diabetes (2 years)
- **Family History:** Father (MI at 52), Mother (hypertension)
- **Social History:** Current smoker (15 cigarettes/day), social alcohol
- **Medications:** 
  - Metformin 1000mg BID
  - Lisinopril 10mg daily
  - Atorvastatin 20mg daily

### Chief Complaint
"I've been having chest pain when I exercise or climb stairs. It's a squeezing sensation that goes away when I rest."

### Primary Care Visit
- **Visit Date:** Today
- **Provider:** Family medicine physician
- **Chief Complaint:** Exertional chest pain for 2 weeks

### Presentation Details
- **Onset:** 2 weeks ago, gradual
- **Triggers:** Physical exertion, climbing stairs, emotional stress
- **Duration:** 3-5 minutes with rest
- **Quality:** Squeezing, pressure-like
- **Radiation:** Left arm occasionally
- **Associated Symptoms:** None significant

### Physical Examination
- **Vital Signs:** BP 148/92 mmHg, HR 82, BMI 26.5
- **General:** Well-appearing, no acute distress
- **Cardiovascular:** Regular rhythm, no murmurs, pulses intact
- **Respiratory:** Clear to auscultation

### Initial Workup
- **ECG:** Sinus rhythm, normal axis, no ST-T changes
- **Chest X-ray:** Normal heart size, clear lung fields
- **Basic Labs:** Normal CBC, BMP

### Risk Stratification

#### ASCVD Risk Assessment
- **Age:** 45 years
- **Sex:** Male
- **Smoking:** Current smoker (15 pack-years)
- **Diabetes:** Type 2 (2 years)
- **Hypertension:** Yes (5 years)
- **Cholesterol:** LDL 145 mg/dL

- **10-Year ASCVD Risk:** 12.3% (high risk, >10%)
- **Diabetes + 1 risk factor:** High risk category

### Referral Decision

#### When to Refer to Cardiology
1. **High-Risk Features Present:**
   - **Exertional chest pain** ✓
   - **Multiple cardiac risk factors** ✓
   - **High ASCVD risk** ✓
   - **Diabetes** (equivalent to coronary disease)

2. **Non-Invasive Testing Indicated:**
   - **Symptomatic patient** with risk factors
   - **Intermediate-high pretest probability**
   - **Requires definitive diagnosis**

#### Referral Urgency
- **Semi-urgent:** Not immediate emergency, but needs prompt evaluation
- **Timeline:** Within 2-4 weeks
- **Patient Education:** Stop exertion, carry nitroglycerin

### Referral Process

#### Referral Documentation
1. **History and Physical:** Complete documentation
2. **Risk Assessment:** ASCVD risk calculation
3. **Previous Testing:** ECG, CXR results attached
4. **Differential Diagnosis:** Coronary artery disease most likely

#### Patient Preparation
1. **Cardiology Appointment:** Scheduled in 3 weeks
2. **Preparation Instructions:**
   - **Bring all medications**
   - **Wear comfortable clothing**
   - **Fast if stress test planned**
   - **List of questions** prepared

### Cardiology Evaluation

#### Cardiology Assessment
- **History:** Consistent with stable angina
- **Physical Exam:** Unchanged, cardiovascular normal
- **Review of Primary Care Workup:** Adequate initial evaluation

#### Recommended Testing
1. **Non-Invasive Stress Testing:**
   - **Exercise Stress Test:** Good exercise tolerance
   - **Alternative:** Nuclear stress test if limited exercise
   - **Goal:** Assess for inducible ischemia

2. **Laboratory Studies:**
   - **Lipid panel:** Complete
   - **HbA1c:** Diabetes monitoring
   - **BNP:** Baseline

#### Expected Testing Results
- **Exercise Stress Test:** Positive at 8 minutes, 5 METs
- **Peak heart rate:** 150 bpm (target 85% age-predicted)
- **ST depression:** 2mm in V4-V6 at peak exercise
- **Symptoms:** Reproduced chest pain

### Final Diagnosis and Treatment

#### Diagnosis
- **Coronary Artery Disease:** Single vessel disease (LAD)
- **Stable Angina:** Class I (ordinary activity doesn't cause symptoms)
- **Functional Capacity:** Moderate (5 METs)

#### Treatment Plan
1. **Medical Management:**
   - **Aspirin 81mg daily**
   - **Beta-blocker:** Metoprolol 25mg BID
   - **ACE inhibitor:** Continue lisinopril
   - **Statin:** High-intensity (atorvastatin 80mg)

2. **Lifestyle Modifications:**
   - **Smoking cessation:** Mandatory
   - **Exercise program:** Cardiac rehabilitation
   - **Diet:** Mediterranean diet
   - **Weight loss:** 15-20 lbs target

3. **Follow-up:**
   - **Cardiology:** 3 months
   - **Primary care:** Monthly until stable
   - **Rehabilitation:** 3x/week for 12 weeks

### Learning Objectives
- Risk stratify patients with chest pain
- Recognize appropriate referral criteria
- Understand non-invasive testing selection
- Apply evidence-based secondary prevention
- Coordinate care between primary and specialty providers

---

## Scenario 2: Neurology Referral - Cognitive Decline

### Patient Profile
- **Name:** Eleanor Thompson
- **Age:** 74 years
- **Gender:** Female
- **Weight:** 135 lbs (61 kg)
- **Height:** 5'6" (168 cm)
- **BMI:** 21.5
- **Occupation:** Retired librarian

### Medical History
- **Primary Reason:** Memory concerns and cognitive changes
- **Medical History:**
  - Hypertension (15 years)
  - Osteoarthritis
  - Vitamin D deficiency
- **Social History:** Lives alone, widowed 2 years ago
- **Medications:** 
  - Amlodipine 5mg daily
  - Acetaminophen 650mg TID
  - Vitamin D3 1000 IU daily

### Chief Complaint (from family)
"My mother's memory has been getting worse over the past year. She's forgetting appointments, repeating questions, and had trouble finding her way home from the grocery store."

### Timeline of Symptoms
- **1 year ago:** Mild forgetfulness, occasional repetition
- **6 months ago:** Increased confusion, getting lost
- **3 months ago:** Difficulty with complex tasks
- **Current:** Functional impairment, safety concerns

### Primary Care Assessment

#### Cognitive Screening
1. **Mini-Mental State Examination (MMSE):**
   - **Score:** 18/30 (impaired, normal >24)
   - **Orientation:** Some difficulty with time
   - **Memory:** Poor recall and delayed recall
   - **Attention/Calculation:** Impaired serial 7s
   - **Language:** Mild difficulty with naming

2. **Functional Assessment:**
   - **Instrumental ADLs:** Impaired (medication management, finances)
   - **Basic ADLs:** Intact (eating, dressing, toileting)
   - **Safety concerns:** Getting lost, missed medications

#### History from Family
- **Progressive decline** over 12 months
- **Memory problems** most prominent
- **Personality changes:** Increased irritability
- **Language:** Occasional word-finding difficulty
- **Behavior:** No aggression or sundowning

### Referral Decision

#### When to Refer to Neurology
1. **Cognitive Impairment Present:**
   - **MMSE <24** ✓
   - **Functional impairment** ✓
   - **Progressive decline** ✓

2. **Need for Comprehensive Evaluation:**
   - **Differential diagnosis:** Dementia vs. other causes
   - **Formal neurocognitive testing**
   - **Neuroimaging:** MRI brain
   - **Specialist management**

#### Referral Urgency
- **Routine referral:** Not urgent, but concerning symptoms
- **Timeline:** Within 6 weeks
- **Safety considerations:** Living alone, driving ability

### Referral Documentation

#### Comprehensive History
1. **Cognitive Symptoms:**
   - **Timeline:** Progressive over 1 year
   - **Domains affected:** Memory, executive function
   - **Functional impact:** ADL impairment
   - **Behavioral changes:** Mild irritability

2. **Safety Assessment:**
   - **Living situation:** Alone, independent
   - **Driving:** Family concerned about safety
   - **Medication compliance:** Missed doses reported
   - **Cooking/meals:** Adequate with reminders

3. **Family Concerns:**
   - **Progression:** Steady decline
   - **Stress on caregiver:** Daughter primary support
   - **Financial concerns:** May need assistance

### Neurology Evaluation

#### Comprehensive Assessment
1. **Detailed Neurological History:**
   - **Cognitive domains:** Memory, language, visuospatial, executive
   - **Non-cognitive symptoms:** Sleep, mood, behavior
   - **Neurological review:** Headaches, seizures, movement disorders

2. **Physical Examination:**
   - **Cognitive testing:** MoCA (Montreal Cognitive Assessment)
   - **MoCA Score:** 16/30 (severe impairment)
   - **Neurological exam:** Normal motor, sensory, reflexes
   - **Parkinsonism:** No bradykinesia or rigidity

#### Diagnostic Studies
1. **Neuroimaging:**
   - **MRI Brain:** Global cortical atrophy, hippocampal atrophy
   - **Vascular changes:** Mild small vessel disease
   - **Midline shift:** None
   - **Stroke history:** No evidence

2. **Laboratory Studies:**
   - **Thyroid function:** Normal TSH
   - **B12:** Normal
   - **RPR:** Non-reactive
   - **Inflammatory markers:** Normal ESR/CRP

### Diagnosis and Management

#### Primary Diagnosis
- **Alzheimer's Disease:** Probable (NIA-AA criteria)
- **Severity:** Mild-to-moderate dementia
- **Functional Status:** Impaired instrumental ADLs

#### Treatment Plan
1. **Pharmacological:**
   - **Cholinesterase inhibitor:** Donepezil 5mg daily → 10mg
   - **Target dose:** 10mg daily
   - **Timeline:** Gradual titration over 4 weeks

2. **Non-pharmacological:**
   - **Cognitive stimulation:** Day program referral
   - **Exercise program:** Improves cognition and mood
   - **Sleep hygiene:** Regular routine, avoid daytime napping

3. **Safety Measures:**
   - **Home safety evaluation:** Occupational therapy
   - **Driving assessment:** Formal evaluation needed
   - **Medication management:** Pill organizer, caregiver oversight

### Care Coordination

#### Multidisciplinary Team
1. **Primary Care Physician:**
   - **Continuity of care**
   - **Medical management**
   - **Preventive care**

2. **Neurologist:**
   - **Diagnostic confirmation**
   - **Medication management**
   - **Disease monitoring**

3. **Other Specialists:**
   - **Occupational therapy:** Home safety
   - **Physical therapy:** Exercise program
   - **Social work:** Resources and support
   - **Psychiatry:** Behavioral management if needed

#### Family Support
1. **Caregiver Education:**
   - **Disease progression:** Expected timeline
   - **Communication strategies**
   - **Safety precautions**
   - **Respite care options**

2. **Resources:**
   - **Alzheimer's Association:** Support groups
   - **Area Agency on Aging:** Adult day programs
   - **Legal planning:** Power of attorney, advance directives

### Follow-up Plan
- **Neurology:** Every 6 months
- **Primary care:** Every 3 months
- **Medication monitoring:** Every 3 months
- **Functional assessment:** Every 6 months

### Learning Objectives
- Screen for cognitive impairment appropriately
- Recognize dementia syndromes
- Apply diagnostic criteria for Alzheimer's disease
- Coordinate multidisciplinary dementia care
- Support patients and families through diagnosis

---

## Scenario 3: Endocrinology Referral - Uncontrolled Diabetes

### Patient Profile
- **Name:** Carlos Martinez
- **Age:** 58 years
- **Gender:** Male
- **Weight:** 190 lbs (86 kg)
- **Height:** 5'8" (173 cm)
- **BMI:** 28.9
- **Occupation:** Construction worker

### Medical History
- **Primary Reason:** Poorly controlled diabetes
- **Medical History:**
  - Type 2 diabetes (15 years)
  - Diabetic nephropathy (CKD Stage 3)
  - Diabetic retinopathy (mild)
  - Peripheral neuropathy
- **Medications:** 
  - Metformin 2000mg daily
  - Glipizide 10mg BID
  - Lantus 40 units at bedtime
  - Lisinopril 20mg daily
  - Atorvastatin 40mg daily

### Chief Complaint
"My blood sugars have been running very high despite increasing my insulin. I'm also having more swelling in my legs and feeling more tired."

### Current Issues
- **Glycemic Control:** Poor (HbA1c 9.8%)
- **Symptom Progression:** Increased fatigue, peripheral edema
- **Medication Issues:** Insulin resistance
- **Kidney Function:** Declining (eGFR 35 mL/min/1.73m²)

### Primary Care Assessment

#### Laboratory Results
- **HbA1c:** 9.8% (target <7%)
- **Fasting Glucose:** 245 mg/dL (target 80-130 mg/dL)
- **Random Glucose:** 320 mg/dL
- **CMP:**
  - Creatinine: 2.1 mg/dL (elevated from 1.6)
  - eGFR: 35 mL/min/1.73m² (CKD Stage 3b)
  - Potassium: 5.2 mEq/L (elevated)
- **Urinalysis:** Proteinuria, microalbuminuria

#### Complications Assessment
1. **Diabetic Nephropathy:**
   - **Progressive CKD** (stage 3b)
   - **Proteinuria** present
   - **Hyperkalemia** (K+ 5.2 mEq/L)

2. **Cardiovascular Risk:**
   - **Diabetic complications** present
   - **Hypertension** (170/95 mmHg today)
   - **Dyslipidemia** (LDL 125 mg/dL)

### Referral Decision

#### When to Refer to Endocrinology
1. **Poor Glycemic Control:**
   - **HbA1c >9% despite maximal therapy**
   - **Insulin resistance** (requiring >1 unit/kg/day)

2. **Complications Present:**
   - **Progressive nephropathy**
   - **Retinopathy**
   - **Neuropathy**

3. **Complex Management:**
   - **Advanced CKD** complicating medications
   - **Hyperkalemia** (needs specific management)
   - **Cardiovascular risk** optimization

#### Referral Urgency
- **Urgent:** Progressive CKD, hyperkalemia
- **Timeline:** Within 2 weeks
- **Safety concerns:** Cardiovascular risk, kidney function

### Referral Documentation

#### Comprehensive Summary
1. **Diabetes History:**
   - **Duration:** 15 years
   - **Current regimen:** Metformin, glipizide, basal insulin
   - **Previous regimens:** Multiple oral agents tried

2. **Complications:**
   - **Nephropathy:** Progressive CKD Stage 3b
   - **Retinopathy:** Mild non-proliferative
   - **Neuropathy:** Peripheral sensory
   - **Cardiovascular:** No known CAD

3. **Recent Changes:**
   - **Kidney function:** Decline over past 6 months
   - **Potassium:** New hyperkalemia
   - **BP control:** Worsening hypertension

### Endocrinology Assessment

#### Initial Evaluation
1. **Comprehensive History:**
   - **Diabetes education:** Previous formal training
   - **Monitoring:** Home glucose checks, frequency
   - **Dietary habits:** Potential improvements needed
   - **Exercise:** Limited by work and kidney function

2. **Physical Examination:**
   - **Weight:** Stable (no weight loss/gain)
   - **Edema:** Bilateral lower extremity pitting edema
   - **Retinopathy:** Mild background changes
   - **Neuropathy:** Decreased sensation in feet

#### Laboratory Review
1. **Advanced Diabetes Studies:**
   - **HbA1c:** 9.8% (poor control)
   - **Fructosamine:** Elevated (confirming poor control)
   - **C-peptide:** 1.2 ng/mL (low, indicating beta cell failure)
   - **Autoantibodies:** GAD negative (type 2 diabetes confirmed)

2. **Nephrology Workup:**
   - **24-hour urine protein:** 1.8g/day (nephrotic range)
   - **Kidney ultrasound:** No obstruction, normal size
   - **Referral needed:** Nephrology for CKD management

### Management Plan

#### Diabetes Optimization
1. **Insulin Regimen Modification:**
   - **Discontinue glipizide** (sulfonylurea, limited benefit in CKD)
   - **Basal insulin:** Increase Lantus to 60 units
   - **Consider:** GLP-1 receptor agonist (if eGFR >30)

2. **Medication Adjustments:**
   - **Continue metformin** (dose adjustment needed)
   - **Add SGLT-2 inhibitor** (dapagliflozin 5mg daily)
   - **Cardiovascular/renal benefits**

3. **CKD Management:**
   - **Nephrology referral:** For proteinuria management
   - **Dietary counseling:** Protein restriction consideration
   - **BP control:** Target <130/80 mmHg

#### Lifestyle Modifications
1. **Medical Nutrition Therapy:**
   - **Carbohydrate counting**
   - **Protein restriction** (0.8 g/kg/day)
   - **Potassium restriction** (2-3g/day)
   - **Fluid restriction** if edema worsens

2. **Physical Activity:**
   - **Low-impact exercise:** Walking, swimming
   - **Frequency:** 30 minutes daily
   - **Monitor kidney function** with exercise

### Coordination of Care

#### Multidisciplinary Approach
1. **Endocrinology:**
   - **Diabetes management**
   - **Medication optimization**
   - **Glycemic targets**

2. **Nephrology:**
   - **CKD progression**
   - **Proteinuria management**
   - **Kidney replacement planning**

3. **Cardiology:**
   - **CV risk assessment**
   - **Heart failure risk** (if progresses)

#### Communication Plan
- **Monthly endocrine visits** initially
- **Quarterly nephrology** for CKD
- **Primary care** for overall coordination
- **Shared medical record** for coordination

### Expected Outcomes
- **HbA1c target:** <8% (relaxed due to CKD)
- **CKD progression:** Slow progression
- **Cardiovascular protection:** SGLT-2 inhibitor benefits
- **Quality of life:** Improved with better glycemic control

### Learning Objectives
- Recognize when to refer to endocrinology
- Understand diabetes complications management
- Apply ADA Standards of Care for CKD
- Coordinate multidisciplinary care
- Balance glycemic targets with complications

---

## Additional Referral Scenarios

### Gastroenterology Referral
- **Patient:** 50-year-old with Barrett's esophagus
- **Key points:** Dysplasia management, surveillance protocols
- **Learning objectives:** GI specialty coordination

### Rheumatology Referral
- **Patient:** 45-year-old with rheumatoid arthritis
- **Key points:** DMARD initiation, disease monitoring
- **Learning objectives:** Autoimmune disease management

### Ophthalmology Referral
- **Patient:** 60-year-old diabetic with retinopathy
- **Key points:** Screening protocols, treatment decisions
- **Learning objectives:** Vision care coordination

### Psychiatry Referral
- **Patient:** 35-year-old with major depression
- **Key points:** Medication management, therapy coordination
- **Learning objectives:** Mental health integration

---

## Referral Guidelines and Best Practices

### Referral Criteria
1. **Diagnostic Uncertainty:** Complex presentations
2. **Specialized Treatment:** Procedures or medications
3. **Poor Response:** Primary treatment failure
4. **Complications:** Disease progression
5. **Preventive Care:** Screening recommendations

### Documentation Requirements
1. **Chief Complaint:** Clear reason for referral
2. **History and Physical:** Comprehensive documentation
3. **Previous Testing:** All relevant studies
4. **Current Treatments:** Medications and responses
5. **Provider Communication:** Response expectations

### Quality Measures
- **Timely referral processing**
- **Appropriate referral criteria**
- **Complete documentation**
- **Follow-up coordination**
- **Patient satisfaction**

---

*Note: All scenarios are fictional and created for educational purposes. Patient information has been de-identified and modified for demonstration.*